Jose M. Galarza, DVM, PhD, is the CEO and Founder of TechnoVax, Inc. and has more than 30 years of experience in the field of virology and vaccine development. Before founding TechnoVax, he was Principal Scientist and leader of the influenza subunit vaccine development program and member of the vaccine technology advisory board at Wyeth Pharmaceuticals. At Wyeth, he led the team that invented influenza Virus-Like Particle (VLP) vaccine technology. Dr. Galarza received a Doctorate in Veterinary Medicine and a Doctorate in Microbiology from the University of La Plata in Argentina.
Insights from a Global Collaboration Accelerating Vaccine Development with an Optimized VLP Platform The COVID-19 pandemic further emphasized…
